Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

Recent & Breaking News (NDAQ:NVCN)

Shockwave Medical (NDAQ:SWAV) completes Neovasc (TSX:NVCN) acquisition

Jonathon Brown April 11, 2023

Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update

GlobeNewswire March 31, 2023

Neovasc Shareholders Approve Acquisition by Shockwave Medical

GlobeNewswire March 6, 2023

Health @ home: The multibillion-dollar medical device market

Jonathon Brown February 22, 2023

Neovasc Announces German Reimbursement Renewal

GlobeNewswire February 1, 2023

Moore Kuehn Encourages NVCN, VLTA, CNCE, and ANGN Investors to Contact Law Firm

PR Newswire January 21, 2023

Shockwave Medical (TSX:NVCN) to acquire Neovasc

Brieanna McCutcheon  January 17, 2023

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Neovasc Inc. (NVCN)

Newsfile January 17, 2023

IIROC Trade Resumption - NVCN

Canada NewsWire January 17, 2023

IIROC Trading Halt - NVCN

Canada NewsWire January 17, 2023

Shockwave Medical Announces Agreement to Acquire Neovasc

GlobeNewswire January 17, 2023

Shockwave Medical to Acquire Neovasc

GlobeNewswire January 17, 2023

Neovasc Announces Progress on COSIRA-II Clinical Trial

GlobeNewswire November 28, 2022

Neovasc Comments on European Heart Journal Publication

GlobeNewswire November 18, 2022

Neovasc Announces Third Quarter Financial Results and Provides Corporate Update

GlobeNewswire November 10, 2022

Neovasc Reducer Obtains U.S. Outpatient Reimbursement

GlobeNewswire November 8, 2022

Neovasc to Report Third Quarter Financial Results on November 10, 2022

GlobeNewswire October 27, 2022

Neovasc (TSX:NVCN) Reducer shows efficacy

Caroline Egan  September 20, 2022

Neovasc Provides Corporate Update Following Clinical Data Release

GlobeNewswire September 20, 2022

Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit

GlobeNewswire September 16, 2022